Citation

Borsari C, Rageot D, Beaufils F, Bohnacker T, Keles E, Buslov I, Melone A, Sele AM, Hebeisen P, Fabbro D, Hillmann P, Wymann MP.: Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl-Pyrimidine Moiety. ACS Med Chem Lett, Volume 10 (10), 2019

Authors

Beaufils F, Bohnacker T, Borsari C, Buslov I, Fabbro D, Hebeisen P, Hillmann P, Keles E, Melone A, Rageot D, Sele AM, Wymann MP.

Journal

ACS Med Chem Lett

Year

2019

DOI

10.1021/acsmedchemlett.9b00333

PubMed

31620236

Machine-readable

REST APIRDF